Stockscreener 앱 받기
13.34
3.30%
-0.455
전일 마감가:
$13.79
열려 있는:
$13.67
하루 거래량:
101.32K
Relative Volume:
0.47
시가총액:
$551.00M
수익:
$771.65M
순이익/손실:
$-120.49M
주가수익비율:
-4.1803
EPS:
-3.19
순현금흐름:
$-73.76M
1주 성능:
-5.56%
1개월 성능:
-8.54%
6개월 성능:
-24.70%
1년 성능:
-1.95%
1일 변동 폭
$13.33
$13.68
1주일 범위
$13.33
$14.44
52주 변동 폭
$12.08
$20.73
Orthofix Medical Inc Stock (OFIX) Company Profile
명칭
Orthofix Medical Inc
전화
214-937-2000
주소
3451 PLANO PARKWAY, LEWISVILLE, TX
OFIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
13.34 | 551.00M | 771.65M | -120.49M | -73.76M | -3.19 |
|
ABT
Abbott Laboratories
|
132.41 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.54 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.81 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.67 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.49 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-22 | 개시 | Canaccord Genuity | Buy |
| 2024-11-08 | 업그레이드 | Stifel | Hold → Buy |
| 2024-05-08 | 업그레이드 | ROTH MKM | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-09-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-09-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-07-19 | 재개 | BTIG Research | Buy |
| 2022-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2019-10-29 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-06-14 | 개시 | Ladenburg Thalmann | Buy |
| 2017-05-23 | 개시 | SunTrust | Buy |
| 2015-07-10 | 개시 | Sidoti | Buy |
| 2013-05-09 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2013-01-08 | 재확인 | Mizuho | Buy |
| 2010-06-21 | 개시 | Boenning & Scattergood | Outperform |
| 2010-03-09 | 재확인 | Jefferies & Co | Buy |
| 2010-02-18 | 업그레이드 | Susquehanna Financial | Neutral → Positive |
| 2010-01-22 | 개시 | Jefferies & Co | Buy |
| 2009-11-03 | 업그레이드 | Wells Fargo | Underperform → Market Perform |
| 2009-07-31 | 재확인 | Jefferies & Co | Buy |
| 2009-07-31 | 업그레이드 | Thomas Weisel | Market Weight → Overweight |
| 2009-05-26 | 재확인 | Jefferies & Co | Buy |
| 2009-04-17 | 다운그레이드 | Wachovia | Mkt Perform → Underperform |
| 2009-02-19 | 개시 | Canaccord Adams | Buy |
| 2008-07-07 | 다운그레이드 | Wachovia | Outperform → Mkt Perform |
모두보기
Orthofix Medical Inc 주식(OFIX)의 최신 뉴스
Orthofix Medical Inc (OFIX) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix Medical, Bioventus - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
Orthofix Medical CLO Sells Shares to Cover Tax Obligations - TradingView
Where are the Opportunities in (OFIX) - news.stocktradersdaily.com
Orthofix to Report First Quarter 2025 Financial Results | OFIX S - GuruFocus
Orthofix to Report First Quarter 2025 Financial Results | OFIX Stock News - GuruFocus
Orthofix to Report First Quarter 2025 Financial Results - Business Wire
Exponential Growth Expected for Pelvis External Fixation - openPR.com
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Orthofix Medical Inc.(OFIX) Shareholders - ACCESS Newswire
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
Orthofix Medical’s SWOT analysis: spine firm’s stock faces growth hurdles By Investing.com - Investing.com Canada
OFIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Orthofix Medical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Orthofix Medical's SWOT analysis: spine firm's stock faces growth hurdles - Investing.com
Orthofix Signs New Lease Agreement in Carlsbad - TipRanks
Orthofix Medical (NASDAQ:OFIX investor three-year losses grow to 55% as the stock sheds US$58m this past week - simplywall.st
Faruqi & Faruqi Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024OFIX - MarketScreener
Orthofix Medical CAO sells $1,196 in stock - Investing.com Australia
Orthofix Medical CAO sells $1,196 in stock By Investing.com - Investing.com Canada
Levi & Korsinsky Notifies Shareholders of Orthofix Medical Inc. (OFIX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
ATTENTION OFIX SHAREHOLDERS: Investors who lost money on Orthofix Medical Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire
Orthofix stock holds rating after Q4 results beat By Investing.com - Investing.com Canada
Orthofix stock holds rating after Q4 results beat - Investing.com
Bone Growth Stimulator Market Is Booming Worldwide | Orthofix Medical Inc., Medtronic, Zimmer Biomet, Bioventus Inc - openPR.com
ORTHOFIX MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orthofix - ACCESS Newswire
Orthofix medical CAO sells shares worth $4,913 By Investing.com - Investing.com South Africa
Orthofix Medical Officer Sells Shares to Cover Tax Obligations - TradingView
Orthofix medical CAO sells shares worth $4,913 - Investing.com
Orthofix Medical’s CP&BOO vitale Lucas sells $71,164 in stock By Investing.com - Investing.com UK
Minimally Invasive Spine Surgery Instruments Market Is Booming Worldwide | Smith & Nephew plc, Orthofix Medical - openPR
Orthofix Medical’s CP&BOO vitale Lucas sells $71,164 in stock - Investing.com
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Orthofix gets FDA clearance for bone transport system By Investing.com - Investing.com South Africa
Orthofix Says Its Transverse Bone Transport System Receives US FDA, EU CE Mark Approval - MarketScreener
Orthofix gets FDA clearance for bone transport system - Investing.com
Orthofix Medical Inc (OFIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orthofix Medical Inc 주식 (OFIX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Gillespie Geoffrey C | CAO |
Apr 02 '25 |
Sale |
15.74 |
76 |
1,196 |
42,445 |
| Vitale Lucas | CP&BOO |
Mar 18 '25 |
Sale |
16.60 |
4,287 |
71,164 |
135,317 |
| Gillespie Geoffrey C | CAO |
Mar 18 '25 |
Sale |
16.60 |
296 |
4,914 |
42,521 |
| Calafiore Massimo | President & CEO |
Mar 05 '25 |
Buy |
17.43 |
9,914 |
172,801 |
222,404 |
| Gillespie Geoffrey C | CAO |
Feb 03 '25 |
Sale |
17.79 |
767 |
13,645 |
39,323 |
| Gillespie Geoffrey C | CAO |
Feb 04 '25 |
Sale |
18.08 |
187 |
3,381 |
39,136 |
| Andrews Julie | CFO |
Jan 16 '25 |
Sale |
17.89 |
4,655 |
83,278 |
28,312 |
| Calafiore Massimo | President & CEO |
Jan 10 '25 |
Sale |
16.83 |
10,078 |
169,619 |
133,354 |
| Calafiore Massimo | President & CEO |
Jan 13 '25 |
Sale |
17.14 |
9,203 |
157,757 |
124,151 |
| Gillespie Geoffrey C | CAO |
Jan 10 '25 |
Sale |
16.83 |
248 |
4,174 |
40,317 |
9.57%
0.08%
자본화:
|
볼륨(24시간):